Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross-over trial
Language English Country Great Britain, England Media print-electronic
Document type Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
23439479
DOI
10.1016/j.fct.2013.02.023
PII: S0278-6915(13)00132-4
Knihovny.cz E-resources
- MeSH
- Antioxidants administration & dosage MeSH
- Arginine administration & dosage MeSH
- Adult MeSH
- Erythrocytes drug effects metabolism MeSH
- gamma-Glutamyltransferase blood MeSH
- Glutathione blood MeSH
- Glutathione Peroxidase blood MeSH
- Glutathione Reductase blood MeSH
- Glutathione Transferase blood MeSH
- Catalase blood MeSH
- Cross-Over Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Malondialdehyde blood MeSH
- Beverages * MeSH
- Pilot Projects MeSH
- Dietary Supplements * MeSH
- Silybin MeSH
- Silymarin administration & dosage MeSH
- Superoxide Dismutase blood MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antioxidants MeSH
- Arginine MeSH
- gamma-Glutamyltransferase MeSH
- Glutathione MeSH
- Glutathione Peroxidase MeSH
- Glutathione Reductase MeSH
- Glutathione Transferase MeSH
- Catalase MeSH
- Malondialdehyde MeSH
- Silybin MeSH
- Silymarin MeSH
- Superoxide Dismutase MeSH
The study objective was to investigate the potential of a beverage containing silymarin and L-arginine to alter basic physiological and urodynamic parameters in 22 normal healthy men aged 38-59 years. The volunteers drank 500 ml/day beverage without silymarin and L-arginine for 10 days followed, after a 7-day washout period, by the beverage with 400mg silymarin and 295 mg L-arginine for 10 days. Blood and urine samples were collected on days 0, 10 and 27. The beverages were well-tolerated with no adverse effects. Most of the biochemical, hematological and urodynamic parameters remained unchanged. Total antioxidant capacity, total level of antioxidants, lipoperoxidation products (malondialdehyde), advanced oxidation products of proteins in plasma and glutathione, glutathione peroxidase, glutathione reductase, superoxide dismutase and catalase levels in erythrocytes were not influenced. Serum γ-glutamyl transferase, malondialdehyde level and activity of glutathione S-transferase in erythrocytes were lowered at day 27 and the concentration of total plasma SH-groups was higher on day 10. Using an ex vivo system, we found that silymarin/silybin at 10-100 μM is able to adsorb onto human erythrocytes and the complexes displayed antioxidant properties as studied using ex situ square-wave voltammetry. The trial showed that silymarin in vivo may protect erythrocytes against oxidative damage.
References provided by Crossref.org
Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota
Chemo-enzymatic synthesis of silybin and 2,3-dehydrosilybin dimers